A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety, Tolerability, and Immunogenicity of Respiratory Syncytial Virus Prefusion F Subunit Vaccine when Coadministered with Seasonal Inactivated Influenza Vaccine in Adults ≥65 Years of Age.
- Year: 2022
- Type: Vaccine
- Phase: III
- Indication: Healthy